The Good Tech Companies - How Aditxt and Crypto.com are Bridging Biotech and Crypto Finance

Episode Date: August 12, 2025

This story was originally published on HackerNoon at: https://hackernoon.com/how-aditxt-and-cryptocom-are-bridging-biotech-and-crypto-finance. Why Aditxt chose Crypto.com for its digital asset treasury as part of its bitXbio biotech-fintech initiative. Check more stories related to web3 at: https://hackernoon.com/c/web3. You can also check exclusive content about #web3, #blockhcain, #aditxt, #crypto.com, #cryptocurrency, #biotech, #good-company, #crypto.com-news, and more. This story was written by: @ishanpandey. Learn more about this writer by checking @ishanpandey's about page, and for more stories, please visit hackernoon.com. Why Aditxt chose Crypto.com for its digital asset treasury as part of its bitXbio biotech-fintech initiative.

This audio is presented by Hacker Noon, where anyone can learn anything about any technology. How Aditext and Crypto.com are bridging biotech in cryptofinance by a Sean Pondy. Why did Adetects turn to crypto.com to secure its biotech treasury? Adetects, a social innovation platform advancing health technologies, signed an agreement with crypto.com to establish a custodial crypto account. The move supports its plan to back biotech innovation with a digital asset reserve, including Bitcoin. Under the agreement, Crypto.com will serve as custodian for Dexte's proposed digital treasury, using its institutional grade crypto. Com custody service. Adatext common stock also

becomes tradable via crypto. Com's broker-dealer, enabling easier access for crypto-native investors. This signals an integration between biotech financing and digital ascertain for structure. Crypto. Com's platform offers custody services to institution's hand high net worth clients, via a secure end-to-end solution. What is Bitex Bio and why does it matter? BitexBio is Aditextee's crypto-native social platform that aims to bridge financial technology and biotechnology. It supports access to innovations such as immunary programming, ad-immune, early cancer detection, Pirsanta and Women's Health, Adafm, by anchoring biotech projects in a digital treasury and enabling trading of its stock via crypto.com. Adetects aligns its health innovation mission

with next-generation finance. What do the executives say? Eric Anziani, president and COO of Crypto.com, said that businesses are planning for the future with digital asset treasuries and that the company is pleased to support Aditexti's BITex Bioinitiative initiative with best-in-class custody as they engage crypto-native traders. Amro albana, co-founder and CEO of Adetex, described the agreement as a key step in aligning biotech assets with next-generation financial infrastructure. He said the partnership lays the foundation for a platform where Value IS created through innovation and made accessible through digital finance. Final Outlook, this agreement between Aditext and Crypto.com represents a

novel crossroads of biotechnology and cryptocurrency. It offers a glimpse of how digital asset platforms might support early stage health innovation with greater transparency and access. On the positive side, placing digital assets like Bitcoin into a biotech treasury could democratize funding and attract new classes of investors. It also streamlines equity access via a trusted custody service. However, integrating volatile crypto assets into financing models introduces market risk. Aditext must manage fluctuating valuations and regulatory complexity. The success of this strategy depends on its ability to raise sufficient capital for its biotech pipeline and close deals such as its proposed acquisition of EvoFem, expected by the second

half of 2025. My view is that Aditexte's move is bold and forward-looking, blending innovation domains. If executed carefully, it could inspire other health tech firms to explore similar models. But oversight, risk management, and regulatory clarity will be essential to make this a sustainable path. Don't forget to like and share the story. This author is an independent contributor publishing via our business blogging program. Hacker Noon has reviewed the report for quality, but the claims here and belong to the author. Hashtag D.Y.O. Thank you for listening to this Hackernoon story, read by artificial intelligence. Visit hackernoon.com to read, write, learn and publish.